Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/5/24 16:00 | 12/18/23 | BBIO | Health | Drug | Pharmaceutical Preparations | Scott Randal W. | CA | D | 4 | S | -314 | 33.00 | 0 | -10 | 19 | I | ||||||||||||||||
2/20/24 16:03 | 12/15/23 | BBIO | Health | Drug | Pharmaceutical Preparations | Valantine Hannah | CA | D | 4 | S.d | -413 | 35.46 | 0 | -12 | 5 | D | ||||||||||||||||
12/28/23 16:00 | 12/26/23 | BBIO | Health | Drug | Pharmaceutical Preparations | McCormick Frank | CA | D | 1 | S | -4,206 | 42.06 | 0 | -100 | 1,100 | I | ||||||||||||||||
11/20/23 16:00 | 11/17/23 | BBIO | Health | Drug | Pharmaceutical Preparations | Stephenson Brian C | CA | O | Secretar | 8 | S.d | -5,013 | 15.12 | 0 | -332 | 220 | D | |||||||||||||||
11/20/23 16:00 | 11/17/23 | BBIO | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | 8 | S.d | -10,458 | 15.39 | 0 | -679 | 7,182 | D | |||||||||||||||
7/19/23 21:33 | 7/18/23 | BBIO | Health | Drug | Pharmaceutical Preparations | Viking Global Investors LP | CT | T | 1 | S | -52,500 | 35.00 | 0 | -1,500 | 25,121 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |